Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Markus WYSS"'
Autor:
Alexandra Lensch, Hanna Abbas Lindfors, Elke Duwenig, Tobias Fleischmann, Carsten Hjort, Sirpa O. Kärenlampi, Lucie McMurtry, Emily-Denise Melton, Mikael Rørdam Andersen, Ryan Skinner, Markus Wyss, Richard van Kranenburg
Publikováno v:
EFB Bioeconomy Journal, Vol 4, Iss , Pp 100061- (2024)
Microorganisms are used in a variety of sectors, including food and feed production, agricultural or environmental applications, and can be optimized for efficacy, safety and sustainability using modern biotechnology techniques. In the EU, geneticall
Externí odkaz:
https://doaj.org/article/232f984d74f94b5db7fbac0831b9d769
Autor:
Markus Wyss, Dominic Muyldermans
Publikováno v:
Open Access Government. 38:486-487
Biodiversity COP15 - A stepping stone towards effective access and benefit sharing Here, Dominic Muyldermans and Markus Wyss explore the opportunities and challenges on the journey towards effective access and benefit sharing across the globe. The ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5c149c2ed33c266df87b86250267bab
https://doi.org/10.56367/oag-038-10746
https://doi.org/10.56367/oag-038-10746
Autor:
Frank Michiels, Ulrich Feiter, Stéphanie Paquin-Jaloux, Diana Jungmann, Axel Braun, Mary Ann P. Sayoc, Ricard Armengol, Markus Wyss, Bruno David
Publikováno v:
Sustainability, Vol 14, Iss 277, p 277 (2022)
Sustainability; Volume 14; Issue 1; Pages: 277
Sustainability; Volume 14; Issue 1; Pages: 277
Access and benefit sharing (ABS) is a framework which refers to a relatively recent type of legal requirements for access to and use of “genetic resources”. They are based on diverse national and regional laws and regulations, which mostly result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffde512821b5d0d1b2aa3af39e07bbd9
https://www.mdpi.com/2071-1050/14/1/277
https://www.mdpi.com/2071-1050/14/1/277
Autor:
Alexandra Lensch, Elke Duwenig, Hans-Georg Dederer, Sirpa O. Kärenlampi, René Custers, Agnes Borg, Markus Wyss
A large variety of fermentation products are used in food and feed production, but also in other industries, and many of these products are produced with genetically modified microorganisms (GMMs). In food and feed production, prominent examples are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c3bb44ab54254fc6974878df215270
Autor:
Markus Wyss, Diana Jungmann, Stéphanie Paquin-Jaloux, Axel Braun, Bruno David, Ulrich Feiter, Ricard Armengol, Frank Michiels, Mary Ann P. Sayoc
Access and Benefit Sharing (ABS) is a framework which refers to a relatively recent type of legal requirements for access to and/or use of “genetic resources”. They are based on diverse national and regional laws and regulations, which mostly res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe66c2c47797955053a725c7e66686ec
Publikováno v:
EMBO reports. 23(2)
The upcoming UN Biodiversity Conference should address shortfalls of Access and Benefit Sharing systems inspired by the Nagoya Protocol to help improve sustainable use of biodiversity and equitable benefit sharing.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f24235da957a9c80cc822041e3d5edfd
https://pubmed.ncbi.nlm.nih.gov/34927336
https://pubmed.ncbi.nlm.nih.gov/34927336
Autor:
Zoltán Prágai, Ariane Alzinger, Jörg Schuldes, Daniel R. Reuß, Michiel Akeroyd, Fabian M. Commichau, Markus Wyss, Miriam Dormeyer, Rolf Daniel, Rafael Sande, Bastien Chevreux, Werner Bretzel, Hans-Peter Hohmann
Publikováno v:
Metabolic Engineering. 29:196-207
Until now, pyridoxine (PN), the most commonly supplemented B6 vitamer for animals and humans, is chemically synthesized for commercial purposes. Thus, the development of a microbial fermentation process is of great interest for the biotech industry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ce488e76992f4b0fb9be8e04d145c42
https://doi.org/10.1016/j.ymben.2015.03.007
https://doi.org/10.1016/j.ymben.2015.03.007
Autor:
Hans-Peter Hohmann, Markus Wyss, Martin Lehmann, Nicholas Schramek, Adelbert Bacher, Simone Degen
Publikováno v:
FEBS Journal. 276:4119-4129
Riboflavin (III, Fig. 1) was discovered 50 years ago by Kuhn and coworkers (1) as an essential vitamin; it is today produced in large quantities industrially, both by chemical synthesis and by fermentation, and is widely used as a food additive and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2ef9a361e821534af66054e6d5d81d1
https://doi.org/10.1111/j.1742-4658.2009.07118.x
https://doi.org/10.1111/j.1742-4658.2009.07118.x
Autor:
Zoltán Prágai, Hanno Langen, Markus Wyss, Peter Berndt, Sabrina Rodriguez, René A. Brunisholz, Céline Malo, Sabine Arnold, Isabelle Maillet
Publikováno v:
PROTEOMICS. 7:1097-1106
The ambition of systems biology to understand complex biological systems at the molecular level implies that we need to have a concrete and correct understanding of each molecular entity and its function. However, even for the best-studied organism,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cddb20eaf6157df8e3a8fedb684f254
https://doi.org/10.1002/pmic.200600599
https://doi.org/10.1002/pmic.200600599
Publikováno v:
Biotechnology and Bioengineering. 89:219-232
At the onset of glucose-limited continuous cultures, riboflavin production in recombinant Bacillus subtilis declines significantly within 3 generations. This phenomenon was specific to riboflavin production and was not correlated with any other physi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8fbf451a9a03eb0d7ce126e5556d353
https://doi.org/10.1002/bit.20338
https://doi.org/10.1002/bit.20338